BIIB
reuters.dev
http://www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FBIIB.O%2Fkey-developments%2Farticle%2F2471506&ei=oIaaUrm3H4Hl0gG83wE&usg=AFQjCNFEDcqNWCP6bfDvnIxK73fEVzLDqQ
Biogen Idec Inc Issues FY 2012 Guidance
Tuesday, 31 Jan 2012 07:00am EST
Biogen Idec Inc announced that for fiscal 2012, it expects revenue growth to be in the low to mid-single digits versus fiscal 2011, non-GAAP diluted EPS to be between $6.10 and $6.20 and GAAP diluted EPS to be between $5.46 and $5.56.Â 
